Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05344482 · COMPLETED
Trial details
- NCT number
- NCT05344482
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-09
- Primary completion
- 2021-08-31
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.